Rapidly Growing Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Using Adaptive Volumetric Modulated Arc Therapy Followed by Durvalumab Maintenance: A Case Report

Keisuke Sakai; Kota Fujii; Hideki Hanazawa; Mami Sakai; Yurie Tsutsumi; Yasushi Fukuda; Yoko Akaike; Kenji Notohara; Satoshi Itasaka

doi:10.12659/AJCR.934767

31 January 2022 : Case report Japan

Rapidly Growing Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Using Adaptive Volumetric Modulated Arc Therapy Followed by Durvalumab Maintenance: A Case Report

Unusual or unexpected effect of treatment

Keisuke Sakai

^1ABCDEF, Kota Fujii

^1ADEF, Hideki Hanazawa^1ADEF, Mami Sakai^1EF, Yurie Tsutsumi^1E, Yasushi Fukuda^2E, Yoko Akaike^3BE, Kenji Notohara^3E, Satoshi Itasaka^1ADEF*

DOI: 10.12659/AJCR.934767

Am J Case Rep 2022; 23:e934767

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. CT axial images before and during the treatment. A (Day −37), B (Day −18), C (Day −4), D (Day 11), E (Day 29), F (Day 51), G (Day 282). A, B, images before treatment; C–F, images during chemoradiotherapy; G: follow-up CT image taken during durvalumab maintenance. The asterisk indicates a primary tumor.

Back to the Article

Rapidly Growing Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Using Adaptive Volumetric Modulated Arc Therapy Followed by Durvalumab Maintenance: A Case Report

Your Privacy